115 products with temporary sales and manufacturing suspension while 104 were cancelled
The number of antihypertensive products containing Chinese ‘Valsartan’ ingredients cancelled in sales suspension was increased from 92 products in the morning to 104 products.
On the 9th, the Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) revealed an additional inspection result ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.